Juvenile myelomonocytic leukemia
Juvenile myelomonocytic leukemia (JMML) is a rare clonal hematopoietic stem cell proliferative disorder that often occurs in childhood.
-
Site of disease:
marrow -
Infectious :
Not contagious -
Frequent population:
childhood -
Related symptoms:
Axillary lymphadenopathy sternal tenderness bone marrow suppression leukocytosis cough
Related Drugs
Asparaginase for injection
Indication: The remission rate of acute lymphocytic leukemia can reach more than 50%. It also has a certain effect on acute myeloid leukemia, acute monocytic leukemia and malignant lymphoma. It is often used in combination with vinblastine, prednisone, cytarabine, mercaptopurine, methotrexate, etc. to improve the efficacy and reduce the occurrence of drug resistance. Vincristine should be administered before asparaginase. If this product is given first, it will damage the liver's clearance of vincristine. The immunosuppressive effect of this product can also be used clinically to treat dermatomyositis.
Manufacturer:
Wuzhi Weierkang Biochemical Pharmaceutical Co., Ltd.
Vinblastine Sulfate Injection
Indication: It is mainly used for the treatment of solid tumors. It has good effects on malignant lymphoma, testicular tumors, and choriocarcinoma. It also has certain effects on lung cancer, breast cancer, ovarian cancer, skin cancer, Wilms tumor, and monocytic leukemia. It can also be used to treat Hodgkin's disease and malignant lymphoma, and choriocarcinoma and breast cancer.
Related Ingredients